Starpharma Holdings Limited

Starpharma Holdings Limited

SPHRF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$151.22M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Starpharma Holdings LimitedStarpharma Holdings Limited-24.9--127%-0.1

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$151.22 Million
Enterprise Value$140.92 Million
Earnings per Share$-0.02
Beta0.77
Outstanding Shares432,069,786

Return

Return on Equity-126.70%ROE
Return on Assets-91.78%
Return on Invested Capital-210.96%

Valuation & Multiples

P/E Ratio-24.85P/E Ratio
PEG-26.99PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue7.87
Enterprise Value to EBIT-4.82
Enterprise Value to Net Income-9
Total Debt to Enterprise0.01
Debt to Equity0.05Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
August 25, 2026
EPS
-$0.01
Reported
Revenue
$842,283
Reported

Next Earnings Call

Expected Date
March 2, 2027
EPS Estimate
-
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Starpharma Holdings Limited

50 employees
CEO: Cheryl Maley

Starpharma Holdings Limited is a global biopharmaceutical firm dedicated to the investigation, advancement, and marketing of its proprietary dendrimer-based products for pharmaceutical, life science, and other diverse applications. Among...